Swapna Vaja

Mr. Swapna Vaja

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 May 2025 in Bioengineering
Verified
Journal Article
Open access
PDF file
Rahul KumarRahul Kumar
Rahul Kumar
KSKyle Chandler Sporn
Kyle Chandler Sporn
Joshua OngJoshua Ong
Joshua Ong
EWEthan Waisberg
Ethan Waisberg
PPPhani Paladugu
Phani Paladugu
MMMouayad Masalkhi
Mouayad Masalkhi
Artificial intelligence (AI) is revolutionizing the field of orthopedic bioengineering by increasing diagnostic accuracy and surgical precision and improving patient outcomes. This review highlights using AI for orthopedics in preoperative planning, intraoperative robotics, smart implants, and bone regeneration. AI-powered imaging, automated 3D anatomical modeling, and robotic-assisted surgery have dramatically changed orthopedic practices. AI has improved surgical planning by enhancing complex image interpretation and providing augmented reality guidance to create highly accurate surgical strategies. Intraoperatively, robotic-assisted surgeries enhance accuracy and reduce human error while minimizing invasiveness. AI-powered smart implant sensors allow for in vivo monitoring, early complication detection, and individualized rehabilitation. It has also advanced bone regeneration devices and neuroprosthetics, highlighting its innovation capabilities. While AI advancements in orthopedics are exciting, challenges remain, like the need for standardized surgical system validation protocols, assessing ethical consequences of AI-derived decision-making, and using AI with bioprinting for tissue engineering. Future research should focus on proving the reliability and predictability of the performance of AI-pivoted systems and their adoption within clinical practice. This review synthesizes recent developments and highlights the increasing impact of AI in orthopedic bioengineering and its potential future effectiveness in bone care and beyond.

25 July 2025 in Life
Verified
Journal Article
Open access
PDF file
KSKyle Chandler Sporn
Kyle Chandler Sporn
Rahul KumarRahul Kumar
Rahul Kumar
KMKiran Marla
Kiran Marla
PRPuja Ravi
Puja Ravi
SVSwapna Vaja
Swapna Vaja
ATAlireza Tavakkoli
Alireza Tavakkoli
Due to their clinical heterogeneity, nonspecific symptoms, and the limitations of existing biomarkers and imaging modalities, metabolic brain diseases (MBDs), such as mitochondrial encephalopathies, lysosomal storage disorders, and glucose metabolism syndromes, pose significant diagnostic challenges. This review examines the growing potential of cell-free DNA (cfDNA) derived from cerebrospinal fluid (CSF) epigenetic profiling as a dynamic, cell-type-specific, minimally invasive biomarker approach for MBD diagnosis and monitoring. We review important technological platforms and their use in identifying CNS-specific DNA methylation patterns indicative of neuronal injury, neuroinflammation, and metabolic reprogramming, including cfMeDIP-seq, enzymatic methyl sequencing (EM-seq), and targeted bisulfite sequencing. By synthesizing current findings across disorders such as MELAS, Niemann–Pick disease, Gaucher disease, GLUT1 deficiency syndrome, and diabetes-associated cognitive decline, we highlight the superior diagnostic and prognostic resolution offered by CSF cfDNA methylation signatures relative to conventional CSF markers or neuroimaging. We also address technical limitations, interpretive challenges, and translational barriers to clinical implementation. Ultimately, this review explores CSF cfDNA epigenetic analysis as a liquid biopsy modality. The central objective is to assess whether epigenetic profiling of CSF-derived cfDNA can serve as a reliable and clinically actionable biomarker for improving the diagnosis and longitudinal monitoring of metabolic brain diseases.

Verified
Journal Article
Open access
PDF file
Rahul KumarRahul Kumar
Rahul Kumar
CGChirag Gowda
Chirag Gowda
TSTejas C Sekhar
Tejas C Sekhar
SVSwapna Vaja
Swapna Vaja
THTami Hage
Tami Hage
ATAlireza Tavakkoli
Alireza Tavakkoli
Artificial intelligence (AI) is reshaping precision medicine by revealing diagnostic links between ocular biomarkers and systemic musculoskeletal disorders. This review synthesizes clinical evidence on the associations between optical coherence tomography (OCT)-derived parameters, such as retinal nerve fiber layer (RNFL) thinning and choroidal thickness, and conditions including osteoporosis, cervical spine instability, and inflammatory arthritis. The findings, based on an analysis of studies that integrate AI with ocular and musculoskeletal imaging, highlight consistent correlations between ocular microstructural changes and systemic degenerative pathologies. These results suggest that the eye may serve as a non-invasive window into biomechanical dysfunction. This review also discusses the emerging role of AI-assisted surgical systems informed by ocular metrics. Overall, AI-driven ocular analysis offers a promising avenue for early detection and management of musculoskeletal disease, supporting its clinical relevance and interdisciplinary potential.

10 September 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
Rahul KumarRahul Kumar
Rahul Kumar
KMKiran Marla
Kiran Marla
PRPuja Ravi
Puja Ravi
KSKyle Chandler Sporn
Kyle Chandler Sporn
RSRohit Srinivas
Rohit Srinivas
ATAlireza Tavakkoli
Alireza Tavakkoli
Joint degeneration is a major global health issue requiring improved diagnostic and prognostic tools. This review examines whether integrating Bayesian graphical models with multiscale medical imaging can enhance detection, analysis, and prediction of joint degeneration compared to traditional single-scale methods. Recent advances in quantitative MRI, such as T2 mapping, enable early detection of subtle cartilage changes, supporting earlier intervention. Bayesian graphical models provide a flexible framework for representing complex relationships and updating predictions as new evidence emerges. Unlike prior reviews that address Bayesian methods or musculoskeletal imaging separately, this work synthesizes these domains into a unified framework that spans molecular, cellular, tissue, and organ-level analyses, providing methodological guidance and clinical translation pathways. Key topics within Bayesian inference include multiscale analysis, probabilistic graphical models, spatial-temporal modeling, network connectivity analysis, advanced imaging biomarkers, quantitative analysis, quantitative MRI techniques, radiomics and texture analysis, multimodal integration strategies, uncertainty quantification, variational inference approaches, Monte Carlo methods, and model selection and validation, as well as diffusion models for medical imaging and Bayesian joint diffusion models. Additional attention is given to diffusion models for advanced medical image generation, addressing challenges such as limited datasets and patient privacy. Clinical translation and validation requirements are emphasized, highlighting the need for rigorous evaluation to ensure that synthesized or processed images maintain diagnostic accuracy. Finally, this review discusses implementation challenges and outlines future research directions, emphasizing the potential for earlier diagnosis, improved risk assessment, and personalized treatment strategies to reduce the growing global burden of musculoskeletal disorders.

7 April 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
Rahul KumarRahul Kumar
Rahul Kumar
KSKyle Chandler Sporn
Kyle Chandler Sporn
Joshua OngJoshua Ong
Joshua Ong
EWEthan Waisberg
Ethan Waisberg
PPPhani Paladugu
Phani Paladugu
MMMouayad Masalkhi
Mouayad Masalkhi
Artificial Intelligence (AI) is revolutionizing the field of orthopedic bioengineering by increasing diagnostic accuracy and surgical precision and improving patient outcomes. This review high-lights using AI for orthopedics in preoperative planning, intra-operative robotics, smart implants, and bone regeneration. AI-powered imaging, automated 3D anatomical modeling, and robot-ic-assisted surgery have dramatically changed orthopedic practices. AI has improved surgical planning by enhancing complex image interpretation and providing augmented reality guidance to create highly accurate surgical strategies. Intraoperatively, robotic-assisted surgeries enhance accuracy and reduce human error while minimizing invasiveness. AI-powered smart implant sensors allow for in vivo monitoring, early complication detection, and individualized rehabilitation. It also has advanced bone regeneration devices and neuroprosthetics, highlighting its innovation capabilities. While AI advancements in orthopedics are exciting, challenges remain, like the need for standardized surgical system validation protocols, assessing ethical consequences of AI-derived decision-making, and using AI with bioprinting for tissue engineering. Future research should focus on proving the reliability and predictability of the performance of AI-pivoted systems and their adoption within clinical practice. This review synthesizes recent developments and highlights the increasing impact of AI in orthopedic bioengineering and its potential future effectiveness in bone care and beyond.

19 June 2026 in The Spine Journal
Verified
Journal Article
Closed access
SSSamer G. Salman
Samer G. Salman
RPRohan A. Phadke
Rohan A. Phadke
RKRahul Kumar
Rahul Kumar
KGKarmen Gill
Karmen Gill
SVSwapna Vaja
Swapna Vaja
CBChristopher Bono
Christopher Bono